Skip to content

Navigating the “Thy” of the Storm: Management of Thyrotoxicosis

Thyrotoxicosis is an endocrine condition of excess thyroid hormone that has many etiologies and manifestations. Thyroid storm represents the severe end of the thyrotoxicosis spectrum and is uncommon, accounting for only 1% to 2% of hospital admissions for thyrotoxicosis, but requires prompt diagnosis and management. The American Thyroid Association (ATA) released updated guidelines in 2016 on the Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. By having an understanding of thyroid storm and the treatment, pharmacists can help provide recommendations and expedite medications to help improve patient care and outcomes. This CE presentation will educate pharmacists on the most up-to-date, evidence-based, guideline-recommended approach to managing thyroid storm.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Explain the pathophysiology and diagnosis of thyroid storm.
  • Discuss guideline recommended treatment options and supportive care for the management of thyroid storm.
  • Identify optimal outpatient monitoring and follow-up after the initial management of thyroid storm.


Emily Duff, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, Massachusetts. Emily is originally from Massachusetts and earned her Doctor of Pharmacy degree in May 2021 from the University of Rhode Island. Emily’s primary interest areas include critical care, emergency medicine, and academia. Emily early committed to the PGY2 Critical Care Pharmacy Residency at Baystate Medical Center for 2021-2022.

Registration Fee: This module is provided free of charge.

Release Date: June 16, 2022
Expiration Date: June 16, 2023
Universal Activity Number: 0026-0000-22-135-L01-P| knowledge-based
Topic Designator:Disease State Management/Drug Therapy
Contact Hours: 1 (0. 1 CEU)


ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1 contact hour (0.1 CEUs).


Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Emily Duff has no financial relationships with ineligible companies.

Residency Director Frank Szcerba has no financial relationships with ineligible companies.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.